ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 043,88
0,64%
Dow Jones
38 686,32
1,51%
DAX
18 680,30
1,07%
Brent Oil
81,26
0,56%
Bitcoin
69 167,52
2,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lantheus Holdings Inc (LNTH)

  7. Lantheus Holdings Inc (LNTH) Actualités

LNTH

Lantheus (LNTH)

Lantheus Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LNTH
DateHeureSourceTitreSymboleSociété
31/05/202422h30Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LNTHLantheus Holdings Inc
31/05/202417h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
30/05/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
28/05/202414h00GlobeNewswire Inc.Lantheus to Present at the William Blair 44th Annual Growth Stock ConferenceNASDAQ:LNTHLantheus Holdings Inc
15/05/202422h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
15/05/202422h30GlobeNewswire Inc.Lantheus Announces Executive Appointments to Accelerate InnovationNASDAQ:LNTHLantheus Holdings Inc
02/05/202413h00GlobeNewswire Inc.Lantheus Reports First Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
18/04/202414h00GlobeNewswire Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
05/03/202414h30GlobeNewswire Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:LNTHLantheus Holdings Inc
04/03/202414h30GlobeNewswire Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric PatientsNASDAQ:LNTHLantheus Holdings Inc
28/02/202414h30GlobeNewswire Inc.Lantheus Announces Promotion of Amanda Morgan to Chief Commercial OfficerNASDAQ:LNTHLantheus Holdings Inc
26/02/202414h30GlobeNewswire Inc.Lantheus to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:LNTHLantheus Holdings Inc
22/02/202413h49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LNTHLantheus Holdings Inc
22/02/202413h00GlobeNewswire Inc.Lantheus Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
13/02/202414h30GlobeNewswire Inc.Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on AgingNASDAQ:LNTHLantheus Holdings Inc
08/02/202414h00GlobeNewswire Inc.Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
23/01/202413h45GlobeNewswire Inc.Lantheus Announces CEO Succession PlanNASDAQ:LNTHLantheus Holdings Inc
11/01/202414h00GlobeNewswire Inc.Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)NASDAQ:LNTHLantheus Holdings Inc
09/01/202414h00GlobeNewswire Inc.Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective TherapeuticsNASDAQ:LNTHLantheus Holdings Inc
09/01/202413h55GlobeNewswire Inc.Lantheus Reports Preliminary Fiscal Year 2023 RevenueNASDAQ:LNTHLantheus Holdings Inc
03/01/202414h30GlobeNewswire Inc.Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
18/12/202313h30GlobeNewswire Inc.Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate CancerNASDAQ:LNTHLantheus Holdings Inc
08/11/202314h00GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
02/11/202312h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
02/11/202312h00GlobeNewswire Inc.Lantheus Reports Third Quarter 2023 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
19/10/202314h00GlobeNewswire Inc.Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
01/09/202314h30GlobeNewswire Inc.Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual MeetingNASDAQ:LNTHLantheus Holdings Inc
31/08/202314h00GlobeNewswire Inc.Lantheus to Present at the Wells Fargo Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
03/08/202313h10GlobeNewswire Inc.Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare RoyaltyNASDAQ:LNTHLantheus Holdings Inc
03/08/202313h00GlobeNewswire Inc.Lantheus Reports Second Quarter 2023 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:LNTH

Dernières Valeurs Consultées

NASDAQ
SAQNW
Software Acquisition
UNSW3
PSPETH
ParaSwap
COIN
PLGTBTC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés